Increased CB^sub 2^ mRNA and anandamide in human blood after cessation of cannabis abuse

In previous studies, long-term cannabis use led to alterations of the endocannabinoid system including an increase in CB^sub 1^ and/or CB^sub 2^ receptor messenger RNA (mRNA) in blood cells and an increase in the serum level of the endocannabinoid 2-arachidonoyl glycerol. However, in those studies,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Naunyn-Schmiedeberg's archives of pharmacology 2014-07, Vol.387 (7), p.691
Hauptverfasser: Muhl, Daniela, Kathmann, Markus, Hoyer, Carolin, Kranaster, Laura, Hellmich, Martin, Gerth, Christoph W, Faulhaber, Johannes, Schlicker, Eberhard, Leweke, F Markus
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page 691
container_title Naunyn-Schmiedeberg's archives of pharmacology
container_volume 387
creator Muhl, Daniela
Kathmann, Markus
Hoyer, Carolin
Kranaster, Laura
Hellmich, Martin
Gerth, Christoph W
Faulhaber, Johannes
Schlicker, Eberhard
Leweke, F Markus
description In previous studies, long-term cannabis use led to alterations of the endocannabinoid system including an increase in CB^sub 1^ and/or CB^sub 2^ receptor messenger RNA (mRNA) in blood cells and an increase in the serum level of the endocannabinoid 2-arachidonoyl glycerol. However, in those studies, cannabis use was stopped only few days before testing or not interrupted at all. Therefore, one cannot decide whether the alterations are due to long-term cannabis abuse or are confounded by acute effects of cannabis. Blood was sampled from donors that had smoked marijuana >=20 times in their lives but had abstained from cannabis for >=6 months (high-frequency users, HFU) and from controls (cannabis use =20 times in their lives and stopped cannabis use at least 6 months before the study show an increase in CB^sub 2^ receptor mRNA in the blood and in serum anandamide level. These alterations resemble those obtained for marijuana smokers that had stopped cannabis use only few days before testing and may be implicated in the pathogenesis of disorders associated with long-term cannabis use.
doi_str_mv 10.1007/s00210-014-0984-2
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1655748910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3594432471</sourcerecordid><originalsourceid>FETCH-proquest_journals_16557489103</originalsourceid><addsrcrecordid>eNqNyr1uwkAQBOBTRCRMkgegW4n6kt3zD3YZEBE0KaIUqUBr-6wY4bvE63t_ruABKGam-EapJeErIa7fBNEQaqRMY1Vm2jyohLLUaKrIzFQSudRkqnKuFiJnRCwozxP1c3DNaFlsC9vNUUIN5gjD1-c7sGtjYvPQtxZ6B79hYAf1xfso3WRHaKwIT7134Dto2DmuewGug9hn9djxRezLbZ_U6mP3vd3rv9H_ByvT6ezD6CKdqMjzdVZWhOl9ryuC5kcE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1655748910</pqid></control><display><type>article</type><title>Increased CB^sub 2^ mRNA and anandamide in human blood after cessation of cannabis abuse</title><source>SpringerLink Journals - AutoHoldings</source><creator>Muhl, Daniela ; Kathmann, Markus ; Hoyer, Carolin ; Kranaster, Laura ; Hellmich, Martin ; Gerth, Christoph W ; Faulhaber, Johannes ; Schlicker, Eberhard ; Leweke, F Markus</creator><creatorcontrib>Muhl, Daniela ; Kathmann, Markus ; Hoyer, Carolin ; Kranaster, Laura ; Hellmich, Martin ; Gerth, Christoph W ; Faulhaber, Johannes ; Schlicker, Eberhard ; Leweke, F Markus</creatorcontrib><description>In previous studies, long-term cannabis use led to alterations of the endocannabinoid system including an increase in CB^sub 1^ and/or CB^sub 2^ receptor messenger RNA (mRNA) in blood cells and an increase in the serum level of the endocannabinoid 2-arachidonoyl glycerol. However, in those studies, cannabis use was stopped only few days before testing or not interrupted at all. Therefore, one cannot decide whether the alterations are due to long-term cannabis abuse or are confounded by acute effects of cannabis. Blood was sampled from donors that had smoked marijuana &gt;=20 times in their lives but had abstained from cannabis for &gt;=6 months (high-frequency users, HFU) and from controls (cannabis use &lt;=5 times lifetime). CB^sub 1^ and CB^sub 2^ mRNA was determined in peripheral mononuclear blood cells using the reverse transcriptase polymerase chain reaction. Serum anandamide level was assayed using electrospray tandem mass spectrometry. CB^sub 2^ mRNA was increased by 45 % in HFU when compared to controls, whereas CB^sub 1^ mRNA did not differ. The anandamide level in HFU exceeded that in controls by 90 %. Tobacco smoking could be excluded as a confounding factor. In conclusion, marijuana users that had smoked marijuana &gt;=20 times in their lives and stopped cannabis use at least 6 months before the study show an increase in CB^sub 2^ receptor mRNA in the blood and in serum anandamide level. These alterations resemble those obtained for marijuana smokers that had stopped cannabis use only few days before testing and may be implicated in the pathogenesis of disorders associated with long-term cannabis use.</description><identifier>ISSN: 0028-1298</identifier><identifier>EISSN: 1432-1912</identifier><identifier>DOI: 10.1007/s00210-014-0984-2</identifier><language>eng</language><publisher>Heidelberg: Springer Nature B.V</publisher><ispartof>Naunyn-Schmiedeberg's archives of pharmacology, 2014-07, Vol.387 (7), p.691</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Muhl, Daniela</creatorcontrib><creatorcontrib>Kathmann, Markus</creatorcontrib><creatorcontrib>Hoyer, Carolin</creatorcontrib><creatorcontrib>Kranaster, Laura</creatorcontrib><creatorcontrib>Hellmich, Martin</creatorcontrib><creatorcontrib>Gerth, Christoph W</creatorcontrib><creatorcontrib>Faulhaber, Johannes</creatorcontrib><creatorcontrib>Schlicker, Eberhard</creatorcontrib><creatorcontrib>Leweke, F Markus</creatorcontrib><title>Increased CB^sub 2^ mRNA and anandamide in human blood after cessation of cannabis abuse</title><title>Naunyn-Schmiedeberg's archives of pharmacology</title><description>In previous studies, long-term cannabis use led to alterations of the endocannabinoid system including an increase in CB^sub 1^ and/or CB^sub 2^ receptor messenger RNA (mRNA) in blood cells and an increase in the serum level of the endocannabinoid 2-arachidonoyl glycerol. However, in those studies, cannabis use was stopped only few days before testing or not interrupted at all. Therefore, one cannot decide whether the alterations are due to long-term cannabis abuse or are confounded by acute effects of cannabis. Blood was sampled from donors that had smoked marijuana &gt;=20 times in their lives but had abstained from cannabis for &gt;=6 months (high-frequency users, HFU) and from controls (cannabis use &lt;=5 times lifetime). CB^sub 1^ and CB^sub 2^ mRNA was determined in peripheral mononuclear blood cells using the reverse transcriptase polymerase chain reaction. Serum anandamide level was assayed using electrospray tandem mass spectrometry. CB^sub 2^ mRNA was increased by 45 % in HFU when compared to controls, whereas CB^sub 1^ mRNA did not differ. The anandamide level in HFU exceeded that in controls by 90 %. Tobacco smoking could be excluded as a confounding factor. In conclusion, marijuana users that had smoked marijuana &gt;=20 times in their lives and stopped cannabis use at least 6 months before the study show an increase in CB^sub 2^ receptor mRNA in the blood and in serum anandamide level. These alterations resemble those obtained for marijuana smokers that had stopped cannabis use only few days before testing and may be implicated in the pathogenesis of disorders associated with long-term cannabis use.</description><issn>0028-1298</issn><issn>1432-1912</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNyr1uwkAQBOBTRCRMkgegW4n6kt3zD3YZEBE0KaIUqUBr-6wY4bvE63t_ruABKGam-EapJeErIa7fBNEQaqRMY1Vm2jyohLLUaKrIzFQSudRkqnKuFiJnRCwozxP1c3DNaFlsC9vNUUIN5gjD1-c7sGtjYvPQtxZ6B79hYAf1xfso3WRHaKwIT7134Dto2DmuewGug9hn9djxRezLbZ_U6mP3vd3rv9H_ByvT6ezD6CKdqMjzdVZWhOl9ryuC5kcE</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Muhl, Daniela</creator><creator>Kathmann, Markus</creator><creator>Hoyer, Carolin</creator><creator>Kranaster, Laura</creator><creator>Hellmich, Martin</creator><creator>Gerth, Christoph W</creator><creator>Faulhaber, Johannes</creator><creator>Schlicker, Eberhard</creator><creator>Leweke, F Markus</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20140701</creationdate><title>Increased CB^sub 2^ mRNA and anandamide in human blood after cessation of cannabis abuse</title><author>Muhl, Daniela ; Kathmann, Markus ; Hoyer, Carolin ; Kranaster, Laura ; Hellmich, Martin ; Gerth, Christoph W ; Faulhaber, Johannes ; Schlicker, Eberhard ; Leweke, F Markus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16557489103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muhl, Daniela</creatorcontrib><creatorcontrib>Kathmann, Markus</creatorcontrib><creatorcontrib>Hoyer, Carolin</creatorcontrib><creatorcontrib>Kranaster, Laura</creatorcontrib><creatorcontrib>Hellmich, Martin</creatorcontrib><creatorcontrib>Gerth, Christoph W</creatorcontrib><creatorcontrib>Faulhaber, Johannes</creatorcontrib><creatorcontrib>Schlicker, Eberhard</creatorcontrib><creatorcontrib>Leweke, F Markus</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muhl, Daniela</au><au>Kathmann, Markus</au><au>Hoyer, Carolin</au><au>Kranaster, Laura</au><au>Hellmich, Martin</au><au>Gerth, Christoph W</au><au>Faulhaber, Johannes</au><au>Schlicker, Eberhard</au><au>Leweke, F Markus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased CB^sub 2^ mRNA and anandamide in human blood after cessation of cannabis abuse</atitle><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle><date>2014-07-01</date><risdate>2014</risdate><volume>387</volume><issue>7</issue><spage>691</spage><pages>691-</pages><issn>0028-1298</issn><eissn>1432-1912</eissn><abstract>In previous studies, long-term cannabis use led to alterations of the endocannabinoid system including an increase in CB^sub 1^ and/or CB^sub 2^ receptor messenger RNA (mRNA) in blood cells and an increase in the serum level of the endocannabinoid 2-arachidonoyl glycerol. However, in those studies, cannabis use was stopped only few days before testing or not interrupted at all. Therefore, one cannot decide whether the alterations are due to long-term cannabis abuse or are confounded by acute effects of cannabis. Blood was sampled from donors that had smoked marijuana &gt;=20 times in their lives but had abstained from cannabis for &gt;=6 months (high-frequency users, HFU) and from controls (cannabis use &lt;=5 times lifetime). CB^sub 1^ and CB^sub 2^ mRNA was determined in peripheral mononuclear blood cells using the reverse transcriptase polymerase chain reaction. Serum anandamide level was assayed using electrospray tandem mass spectrometry. CB^sub 2^ mRNA was increased by 45 % in HFU when compared to controls, whereas CB^sub 1^ mRNA did not differ. The anandamide level in HFU exceeded that in controls by 90 %. Tobacco smoking could be excluded as a confounding factor. In conclusion, marijuana users that had smoked marijuana &gt;=20 times in their lives and stopped cannabis use at least 6 months before the study show an increase in CB^sub 2^ receptor mRNA in the blood and in serum anandamide level. These alterations resemble those obtained for marijuana smokers that had stopped cannabis use only few days before testing and may be implicated in the pathogenesis of disorders associated with long-term cannabis use.</abstract><cop>Heidelberg</cop><pub>Springer Nature B.V</pub><doi>10.1007/s00210-014-0984-2</doi></addata></record>
fulltext fulltext
identifier ISSN: 0028-1298
ispartof Naunyn-Schmiedeberg's archives of pharmacology, 2014-07, Vol.387 (7), p.691
issn 0028-1298
1432-1912
language eng
recordid cdi_proquest_journals_1655748910
source SpringerLink Journals - AutoHoldings
title Increased CB^sub 2^ mRNA and anandamide in human blood after cessation of cannabis abuse
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A41%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20CB%5Esub%202%5E%20mRNA%20and%20anandamide%20in%20human%20blood%20after%20cessation%20of%20cannabis%20abuse&rft.jtitle=Naunyn-Schmiedeberg's%20archives%20of%20pharmacology&rft.au=Muhl,%20Daniela&rft.date=2014-07-01&rft.volume=387&rft.issue=7&rft.spage=691&rft.pages=691-&rft.issn=0028-1298&rft.eissn=1432-1912&rft_id=info:doi/10.1007/s00210-014-0984-2&rft_dat=%3Cproquest%3E3594432471%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1655748910&rft_id=info:pmid/&rfr_iscdi=true